Drugs / Ganglioside-Monosialic Acid
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05239663 | Feb 2022 → Jul 2024 | breast cancer, chemotherapy-induced toxicity | Sun Yat-sen University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT02468739 | May 2015 → Nov 2016 | breast cancer | Sun Yat-sen University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ganglioside-Monosialic Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05239663 ↗ |
| Route | Intravenous | “given once a day via intravenous drip infusion” NCT02468739 ↗ |